Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

AIMS: Adjuvant chemotherapy (ACT) plays an important role in improving the survival of stage II-III colorectal cancer (CRC) patients after curative surgery. However, the prognostic role of irregular delay of ACT (IDacT) for these patients has been less studied. MATERIALS AND METHODS: A total of 117...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuanyuan, Xu, Mingyue, Ye, Qianwen, Xiang, Jia, Xue, Tianhui, Yang, Tao, Liu, Long, Yan, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206266/
https://www.ncbi.nlm.nih.gov/pubmed/35715761
http://dx.doi.org/10.1186/s12885-022-09767-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206266/
https://www.ncbi.nlm.nih.gov/pubmed/35715761
http://dx.doi.org/10.1186/s12885-022-09767-y

Ejemplares similares